SECreport

Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: Ikarian Capital, LLC

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com